Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
IBRX holding history
ImmunityBio, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −16,526−100.0% | Sold out | Holders |
| Q1 2026 | 16,526 | $126.8K | <0.1% | +16,526 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −9,454−100.0% | Sold out | Holders |
| Q4 2022 | 9,454 | $42.0K | <0.1% | −17,260−64.6% | Reduced | Holders |
| Q3 2022 | 26,714 | $144.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 26,714 | $118.0K | <0.1% | +26,714 | New | Holders |